The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Segment by Application
- Iron Deficiency Anemia
- Chronic Kidney Disease related Anemia
- Sickle Cell Anemia
- Aplastic Anemia
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
By Company
- GlaxoSmithKline
- Global Blood Therapeutics (GBT)
- Bluebird Bio
- GlycoMimetics
- Mast Therapeutics
- Fibrogen
- Akebia Therapeutics
- Bayer AG
- Eli Lilly
- Regen Biopharma
- Acceleron Pharma
- Celgene Corporation
- Onconova Therapeutics
- Pieris Pharmaceuticals
